InsidersTradesSigma
Follow the 바이오톡스텍 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 바이오톡스텍 has recorded 17 insider filings. Market capitalisation: €38.4bn. The latest transaction was disclosed on 31 August 2026 (Purchase). Among the most active insiders: 강종구. Every trade is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
17 of 17 declarations
BioToxTech is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the diagnosis and treatment of diseases.